Head to Head Contrast: TNF Pharmaceuticals (TNFA) and Its Rivals
Institutional and Insider Ownership 9.6% of TNF Pharmaceuticals shares are owned by institutional investors. Comparatively, 44.7% of shares of all “Diagnostic substances” companies are owned by institutional investors. 1.2% of TNF Pharmaceuticals shares are owned by company insiders. Comparatively, 12.5% of shares of all “Diagnostic substances” companies are owned by company insiders. Strong institutional ownership […]
Institutional and Insider Ownership 9.6% of TNF Pharmaceuticals shares are owned by institutional investors. Comparatively, 44.7% of shares of all “Diagnostic substances” companies are owned by institutional investors. 1.2% of TNF Pharmaceuticals shares are owned by company insiders. Comparatively, 12.5% of shares of all “Diagnostic substances” companies are owned by company insiders. Strong institutional ownership […]
